Li Wenrui, Liu Bin, Zhu Renming, Qu Wei, Wei Lin, Feng Hai
Department of Vascular Surgery, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Liver Transplantation Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Ann Vasc Surg. 2022 Feb;79:443.e1-443.e6. doi: 10.1016/j.avsg.2021.08.019. Epub 2021 Oct 13.
Portal vein thrombosis (PVT) is an uncommon but serious complication after liver transplantation (LT). Treatments for PVT include thrombolysis, surgical treatment or percutaneous intervention. We here report a case of PVT after LT successfully treated by an AngioJet device using the percutaneous transhepatic approach. A 36-year-old male presented with substantial thrombosis of the portal vein/superior mesenteric vein 2 years after a liver transplant. He was managed with an Angiojet thrombectomy and subsequent stent placement. This approach may be a safe and effective treatment for PVT in post-orthotopic LT patients.
门静脉血栓形成（PVT）是肝移植（LT）后一种罕见但严重的并发症。PVT的治疗方法包括溶栓、手术治疗或经皮介入治疗。我们在此报告一例肝移植后PVT患者，采用经皮经肝途径使用AngioJet装置成功治疗。一名36岁男性在肝移植2年后出现门静脉/肠系膜上静脉大量血栓形成。他接受了AngioJet血栓切除术及随后的支架置入治疗。这种方法可能是原位肝移植术后PVT患者的一种安全有效的治疗方法。
